Glucose regulation influences treatment outcome in ranibizumab treatment for diabetic macular edema

Journal of Diabetes and its Complications

Volumn 25, Issue 5, 2011, Pages 298-302

  Ozturk, Banu Turgut ^a   Kerimoglu, Hurkan ^a   Adam, Mehmet ^a   Gunduz, Kemal ^a   Okudan, Suleyman ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Diabetic macular edema; Glucose regulation; Macular thickness; Ranibizumab

Indexed keywords

BEVACIZUMAB; GLUCOSE; HEMOGLOBIN A1C; RANIBIZUMAB; TRIAMCINOLONE;

ADULT; ARTICLE; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA MACULA LUTEA; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INTRAVITREAL INJECTIONS; MACULA LUTEA; MACULAR EDEMA; MALE; MEDICAL RECORDS; MIDDLE AGED; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTORS; VISUAL ACUITY;

EID: 80052731746     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2010.09.006     Document Type: Article

References (23)

1. Arevalo J.F., Sanchez J.G., Wu L., Maia M., Alezzandrini A.A., Brito M., Bonafonte S., Lujan S., Diaz-Llopis M., Restrepo N., Rodriguez F.J., Udaondo-Mirete P. Pan-American Collaborative Retina Study Group Primary intravitreal bevacizumab for diffuse diabetic macular edema: the Pan-American Collaborative Retina Study Group at 24 months Ophthalmology 116 2009 1488 1497
2. Browning D.J., Glassman A.R., Aiello L.P., Bressler N.M., Bressler S.B., Danis R.P., Davis M.D., Ferris F.L., Huang S.S., Kaiser P.K., Kollman C., Sadda S., Scott I.U., Qin H. Diabetic Retinopathy Clinical Research Network Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema Ophthalmology 115 2008 1366 1371
3. 1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients Diabetes Care 22 1999 1785 1789 (Pubitemid 29521862)
4. Chun D.W., Heier J.S., Topping T.M., Duker J.S., and Bankert J.M. A pilot study of multiple intravitreal injection of ranibizumab in patients with center-involving clinically significant diabetic macular edema Ophthalmology 113 2006 1706 1712 (Pubitemid 44442451)
5. Cunningham E.T. Jr, Adamis A.P., Altaweel M., Aiello L.P., Bresler N.M., D'Amico D.J., Goldbaum M., Guyer D.R., Katz B., Patel M., Schwartz S.D. Macugen Diabetic Retinopathy Study Group A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema Ophthalmology 112 2005 1747 1757 (Pubitemid 41400011)
6. 1c Am J Ophthalmol 139 2005 620 623
7. Early Treatment Diabetic Retinopathy Study Research Group Treatment techniques and clinical guidelines or photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2 Ophthalmology 94 1987 761 774
8. Ferris F.L. III, and Patz A. Macular edema: a complication of diabetic retinopathy Surv Ophthalmol 28 1984 452 461 (Pubitemid 14076504)
9. Forte R., Cennamo G., Vecchio E.C., Tenore R., Aufiero B., and de Crecchio G. Bevacizumab in macular edema: functional and anatomic changes in a prospective case series Retina 29 2009 941 948
10. Funatsu H., Yamashita H., Ikeda T., Mimura T., Eguchi S., and Hori S. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema Ophthalmology 110 2003 1690 1696 (Pubitemid 37025424)
11. Funatsu H., Yamashita H., Sakata K., Noma H., Mimura T., Suzuki M., Eguchi S., and Hori S. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule I are related to diabetic macular edema Ophthalmology 112 2005 806 816 (Pubitemid 40631499)
12. Funk M., Karl D., Georgopoulos M., Benesch T., Sacu S., Polak K., Zlabinger G.J., and Schmidt-Erfurth U. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab Ophthalmology 116 2009 2393 2399
13. Grenga P., Lupo S., Domanico D., and Vingolo E.M. Efficacy of intravitreal triamcinolone acetonide in long standing diabetic macular edema: a microperimetry and optical coherence tomography study Retina 28 2008 1270 1275
14. Klein R., Klein B.E., Moss S.E., Moss S.E., Cruickshanks K.J. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes Ophthalmology 105 1998 1801 1815
15. Kotoula M.G., Koukoulis G.N., Zintzaras E., Karabatsas C.H., and Chatzoulis D.Z. Metabolic control of diabetes is associated with an improved response of diabetic retinopathy to panretinal photocoagulation Diabetes Care 28 2005 2454 2457 (Pubitemid 41384293)
16. Kumagai K., Furukawa M., Ogino N., Larson E., Iwaki M., and Tachi N. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema Retina 29 2009 464 472
17. Marshall J. The role of bevacizumab as first-line therapy for colon cancer Semin Oncol 32 2005 43 47
18. Nguyen Q.D., Shah S.M., Heier J.S., Do D.V., Boyer L.J., Abraham P., Campochiaro P.A. READ-2 Study Group Primary end point (six months) results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) study Ophthalmology 116 2009 2175 2181.e1
19. Nguyen Q.D., TatlIpInar S., Shah M.S., Haller J.A., Quinlan E., Sung J., Zimmer-Galler, Do D.V., and Campochiaro P.A. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema Am J Ophthalmol 142 2006 961 969
20. Ozaki H., Hayashi H., Vinores S.A., Moromizato Y., Campochiaro P.A., and Oshima K. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates Exp Eye Res 64 1997 505 517 (Pubitemid 27321334)
21. Querques G., Bux A.V., Martinelli D., Iaculli C., Del Curatolo M.V., and Noci N.D. Short-term fluctuation of diabetic macular edema after intravitreal ranibizumab injection Retina 29 2009 1274 1281
22. Rodriguez-Fontal M., Kerrison J.B., Alfaro D.V., and Jablon E.P. Metabolic control and diabetic retinopathy Curr Diabetes Rev 5 2009 3 7
23. U.K. Prospective Diabetes Study (UKPDS) Group Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853